The initial reporter received questionable elecsys testosterone ii results from one patient sample tested on the cobas e 801 analytical unit with serial number (b)(6).The initial result was not reported outside of the laboratory.On (b)(6) 2023, the initial result using the primary tube was 1500 ng/dl with a data flag.The reporter then diluted the patient sample to 1:5.It is not clear if the final result of this dilution is 435 ng/dl.Or 500 ng/dl.On (b)(6) 2023, it is not clear if the result of 87.8 ng/dl was a repeat result.Another repeat result using the primary tube was 587 ng/dl.
|
On 26-may-2023, the customer reported a new questionable testosterone result.The initial result was not reported outside of the laboratory.On (b)(6) 2023, the initial result of the undiluted sample was >1500 ng/dl with a data flag.On (b)(6) 2023, the patient sample was diluted at 1:5.The first repeat result using the diluted sample was 7.90 ng/dl.This result was multiplied by the dilution factor of 5 and the result was 39.5 ng/dl.The final dilution result was 40 ng/dl.On (b)(6) 2023, the patient sample was rerun because the dilution result was normal.The second repeat result using the primary tube was 32.1 ng/dl.The third repeat result using the primary tube was 33.4 ng/dl medwatch field b7 was updated.The calibration on (b)(6) 2023 was within specifications.The initial calibration on the same day had a failed result.The qc was within specifications.One reagent rack pack was not quality controlled.The alarm trace could not be translated.The precision check on (b)(6) 2023 was within specifications.A general reagent problem can be excluded because the provided quality validation was within expectations.The investigation did not identify a product problem.The cause of the event could not be determined. .
|